Targeted Therapy for Hodgkin’s Lymphoma

Hodgkin lymphoma is a kind of rare but highly curable cancer of the lymph nodes and the lymphatic system. With appropriate treatment, at least 8 out of 10 individuals can be cured. More individuals survive Hodgkin lymphoma (HL) than any other cancer. Targeted Therapy: Targeted therapy medications attack specific features of cancer cells to halt […]

Chemotherapy for Acute Lymphocytic Leukemia

Acute lymphocytic leukemia (ALL) is also named acute lymphoblastic leukemia, which is the most common hematologic malignancy cancer of bone marrow. It is typically featured by the overproduction of immature lymphoblasts.  Acute lymphocytic leukemia (ALL) is a biologically heterogeneous disorder, so that the morphologic, immunologic, biochemical, cytogenetic, and molecular genetic characterizations of leukemic lymphoblasts are […]

All about T-cell Acute Lymphoblastic Leukaemia

T-cell acute lymphoblastic leukaemia also known as T-ALL is a specific type of leukaemia. It is a variant of acute lymphoblastic leukaemia (ALL), with features identical to some types of lymphoma. T-cell acute lymphoblastic leukaemia (T-ALL) is aggressive and progresses rapidly. It is known for affecting the lymphoid-cell-producing stem cells, in particular a type of […]

Overview of Stage System & Treatment Options of CLL

Stage Information for Chronic Lymphocytic Leukemia: A staging system typically is a standard way for the cancer care specialist to describe cancer. There are basically two different systems for staging Chronic Lymphocytic Leukemia: Rai System: more oftenly used in the United States. Binet System: more widely used in Europe. Both of these staging systems for […]